BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Reuters

01 Apr

BRIEF-Allarity <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Allarity Therapeutics Inc ALLR.O:

ALLARITY THERAPEUTICS: CASH & CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027
ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATION

Source text: ID:nGNX6nrXZ8

Further company coverage: ALLR.O

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2524906485"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524906485\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2524906485?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-01 06:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524906485","market":"nz","top_or_hot":-1,"title":"BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Allarity <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Cash &amp; Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027</title></head><body><p><a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a> <span>ALLR.O</span>:</p><ul><li><p>ALLARITY THERAPEUTICS: CASH &amp; CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027</p></li><li><p>ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATION</p></li></ul><p>Source text: <span>ID:nGNX6nrXZ8</span></p><p>Further company coverage: <span>ALLR.O</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-01 06:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Allarity <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Cash &amp; Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027</title></head><body><p><a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a> <span>ALLR.O</span>:</p><ul><li><p>ALLARITY THERAPEUTICS: CASH &amp; CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027</p></li><li><p>ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATION</p></li></ul><p>Source text: <span>ID:nGNX6nrXZ8</span></p><p>Further company coverage: <span>ALLR.O</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALLR","symbol_name":"Allarity Therapeutics Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE0WU:1","article_id":"2524906485","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524906485","pubTimestamp":1743460983,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027Allarity Therapeutics Inc ALLR.O:ALLARITY ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALLR":"Allarity Therapeutics Inc","BK4139":"生物科技"},"translate_title":"简介-截至12月31日，Allarity Therapeutics现金和应收现金余额为2090万美元，预计将为运营提供资金，包括2027年的临床活动","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALLR":0.9},"content_text":"BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027Allarity Therapeutics Inc ALLR.O:ALLARITY THERAPEUTICS: CASH & CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATIONSource text: ID:nGNX6nrXZ8Further company coverage: ALLR.O","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}